Agilent Technologies Becomes Oversold (A)
MarketNewsVideo.com - Wed Oct 15, 11:19AM CDT
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative...
A: 51.71 (-0.08)
Optical Transceivers: Market Shares, Strategies, and Forecasts, Worldwide, 2014 to 2020
M2 - Wed Oct 15, 8:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/95v7tm/optical) has announced the addition of Wintergreen Research, Inc's new report "Optical Transceivers: Market Shares, Strategies, and Forecasts, Worldwide, 2014 to 2020" to their offering. The global optical transceiver market at $3.2 billion in 2013 is anticipated to grow to $9.9 billion by 2020 driven by the availability and cost effectiveness of 40 Gbps, 100 Gbps, and 400 Gbps devices Next generation devices use less power, are less expensive, and are smaller. The adoption of widespread use of the 100 Gbps devices, and the vast increases in Internet traffic are core to change in the communications infrastructure markets. Leading vendors offer a broad product selection. They are positioned with innovative technology. Optical module manufacturers address the needs of all major networking equipment vendors worldwide. Leading vendors have taken a leading role in transforming the data communications and tele-communications equipment market. The shift has been away from utilizing discrete optical components to leveraging the design and pay-as-you-grow flexibility offered by pluggable modules. Optical transceiver products are compliant with Ethernet, Fibre Channel, SONET/SDH/OTN and PON standards. They generally operate at data rates of 10 Gb/s, 40 Gb/s and 100 Gb/s. Transmitter / Transceivers are capable of distances ranging from very short reach within a datacenter to campus, access, metro, and long-haul reaches. They feature outstanding performance. Units work over extended voltage and temperature ranges. They are positioned to minimize jitter, electromagnetic interference (EMI) and power dissipation. Optical transceiver components are an innovation engine for the network. Optical transceiver components support and enable low-cost transport throughout the network. Optical transceivers are needed for high speed network infrastructure build-outs. These are both for carriers and data centers. Network infrastructure build-out depends on the availability of consultants who are knowledgeable. Key Topics Covered: Optical Transceivers Executive Summary 1. Optical Transceiver Market Description And Market Dynamics 2 Optical Transceivers Market Shares And Market Forecasts 3 Optical Transceiver Product Description 4. Optical Transceiver Technology 5. Optical Transceiver Company Description Companies Mentioned - 3SP Group - ACON - Accelink - Advanced Photonix - Agilent Technologies - Alcatel-Lucent - Analog Devices - Avago Technologies - Broadcom - Champion Optical Network - Cube Optics - Emcore - Emcore Source Photonics - Engineering, LLC (Champion ONE) - Finisar - Finisar JDS Uniphase - Foxconn Technology Group - Fujitsu - Fujitsu Avago - Furukawa Electric - Gigoptix - Huawei - Ikanos - JDSU - Sumitomo - Transmode - Triquint - Vitesse - Zhone Technologies For more information visit http://www.researchandmarkets.com/research/95v7tm/optical Source: Wintergreen Research, Inc
API: 0.48 (+0.01), A: 51.71 (-0.08), ALU: 2.36 (-0.08), ADI: 44.60 (+0.48), AVGO: 75.60 (+3.05)
Global and China DNA Sequencing Industry Research Report, 2014-2017
M2 - Wed Oct 15, 8:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/27g3ds/global_and_china) has announced the addition of the "Global and China DNA Sequencing Industry Research Report, 2014-2017" report to their offering. It is projected that by 2017 this figure will reach USD10.096 billion, exceeding USD10 billion for the first time. DNA sequencing is the process of reading nucleotide bases in a specific DNA molecule, that is to say determining the arrangement mode of adenine, thymine, cytosine, and guanine. It can be applied in a broad range of fields, including medicine, biology, geology, and agriculture. With the advancement of DNA sequencing technology and dramatic decline in sequencing costs, DNA sequencing is increasingly showing its market potential in noninvasive detection, disease diagnosis, and personalized treatment. In 2013, the market size of global DNA sequencing (including equipment and consumables, service and workflow, etc.) approximated USD4.6 billion, up around 26% from the previous year. In China, the upstream sectors of DNA sequencing industry are virtually monopolized by foreign giants. BGI is the leader in China's DNA sequencing service, and its second-generation DNA sequencers top the global chart in number. However, two of its sequencersHiSeq 2000 and Ion Proton were entirely from Illumina and Life Technologies. In March 2013, BGI acquired Complete Genomics, a sign that BGI formally ventured into the upstream sectors of DNA sequencing industry. In June 2014, BGI's two productsBGISEQ-1000 and BGISEQ-100 became the first second-generation DNA sequencers registered in China. Global and China DNA Sequencing Industry Research Report, 2014-2017 mainly focuses on the followings: - Features, cost, etc. of DNA sequencing technology; - Major M&As, genetic database, market size and structure, etc. of global DNA sequencing industry; - Development, industry policies, market structure and prospects, etc. of DNA sequencing industry in China; - Operation, DNA sequencing business, etc. of 12 enterprises at home and abroad. Key Topics Covered: 1. Overview of DNA Sequencing Industry 2. Global DNA Sequencing Industry 3. China DNA Sequencing Industry 4. Key Enterprises - Agilent Technologies - BGI - Berry Genomics - DAAN Gene - Hunan China Sun Pharmaceutical Machinery - Illumina - Jilin Zixin Pharmaceutical Industrial - Pacific Biosciences - Qiagen - Roche - Sequenom - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/27..._and_china
SQNM: 3.31 (+0.10), A: 51.71 (-0.08)
Agilent Technologies announces closure of its Nuclear Magnetic Resonance business
M2 - Wed Oct 15, 7:22AM CDT
Electronic measurement and technology company, Agilent Technologies Inc (NYSE:A) revealed on Tuesday that it will exit its Nuclear Magnetic Resonance business, which it began in 2010 when it acquired Varian.
A: 51.71 (-0.08)
Agilent Technologies Falls 1.89% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Oct 14, 4:49PM CDT
Agilent Technologies (NYSE:A) traded in a range yesterday that spanned from a low of $51.77 to a high of $53.39. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $52.73 on volume of 4.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
A: 51.71 (-0.08)
Why Agilent Technologies (A) Stock Is Down Today
at The Street - Tue Oct 14, 1:47PM CDT
Agilent Technologies (A) is falling Tuesday after the company announced it will close its Nuclear Magnetic Resonance business and reaffirmed its fiscal fourth quarter guidance.
A: 51.71 (-0.08)
Agilent Technologies to Close Nuclear Magnetic Resonance Business
Business Wire - Tue Oct 14, 12:00PM CDT
Agilent Technologies Inc. (NYSE:A) today announced it is exiting its Nuclear Magnetic Resonance business. Agilent entered the NMR business in 2010, with the acquisition of Varian. Since then, the business has not met growth and profitability objectives.
A: 51.71 (-0.08)
Next Support Level for Agilent Technologies (A) is $54.20
Comtex SmarTrend(R) - Fri Oct 10, 9:10AM CDT
Shares of Agilent Technologies (NYSE:A) opened today below their pivot of $55.45 and have already reached the first level of support at $54.61. Investors may be interested in a cross of the next downside pivot targets of $54.20 and $52.95.
A: 51.71 (-0.08)
Global ATCA CPU Blades Market 2014-2018: Key Vendors are ADLINK Technology, Emerson Network Power, Kontron and RadiSys
M2 - Fri Oct 10, 6:04AM CDT
Research and Markets (http://www.researchandmarkets.com/research/f94xs7/global_atca_cpu) has announced the addition of the "Global ATCA CPU Blades Market 2014-2018" report to their offering. ATCA is an industry standard specification created by the PCI Industrial Computer Manufacturers Group for the next generation of carrier-grade communications equipment. ATCA incorporates the latest high-speed interconnect technologies, next-generation processors, and improved reliability, manageability, and serviceability features. It is designed to meet the needs of communication networks infrastructure. It offers several benefits to its end-users such as enabling faster time-to-market, supporting a wider range of products, and allowing entry with low barriers or cost efficiencies. It is most widely use open standard for global telecommunication infrastructure that provides sophisticated and robust system management architecture. The analysts forecast the Global ATCA CPU Blades market to grow at a CAGR of 17.83 percent over the period 2013-2018. In terms of application, the Global ATCA CPU Blades market can be segmented into five: Communications and Network Infrastructure, Military and Aerospace, Industrial Automation and Control, Healthcare, and Others. The report, the Global ATCA CPU Blades Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. ATCA System Architecture 07. Overview of ATCA Standards 08. Market Landscape 09. Market Segmentation by Application 10. Market Segmentation by Technology 11. Market Segmentation by Geography 12. Buying Criteria 13. Market Growth Drivers 14. Drivers and their Impact 15. Market Challenges 16. Impact of Drivers and Challenges 17. Market Trends 18. Trends and their Impact 19. Vendor Landscape 20. Key Vendor Analysis 21. Other Reports in this Series Companies Mentioned: - ADLINK Technology - Emerson Network Power - Kontron - RadiSys - Advantech - Agilent Technologies - Mercury Computer Systems For more information visit http://www.researchandmarkets.com/research/f9...l_atca_cpu
A: 51.71 (-0.08), MRCY: 11.71 (-0.02)
Global Multiplexed Diagnostics Market 2014-2018
M2 - Thu Oct 09, 6:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7pnx6h/global) has announced the addition of the "Global Multiplexed Diagnostics Market 2014-2018" report to their offering. The Global Multiplexed Diagnostics market to grow at a CAGR of 20% over the period 2013-2018 Multiplexed diagnostics refer to equipment that are used for analyzing multiple analytes in the single cycle of the assay procedure. Multiplexed diagnostics can diagnose and run multiple tests on a specimen. These tools are evolved from diagnostic assays that screen a single analyte in a single run of the assay procedure. Multiplexed diagnostics find their use in research laboratories and diagnostics laboratories. Research and development laboratories use multiplexed assays in drug development procedures to screen multiple analytes. Multiplexed diagnostics are used in various fields such as drugs-abuse screening, pharmacogenetics, and infection testing. The Global Multiplexed Diagnostics market can be segmented into revenue generated from various multiplexed diagnostics technologies such as: Medium Density Multiplexed Assays, Low Density Multiplexed Assays, High Density Multiplexed Assays, Very High Density Multiplexed Assays and Next-Generation Sequencing. Expanding economies in the Asia Pacific region is a major trend in the market. The governments in emerging countries are making efforts to improve the healthcare infrastructure, which has benefited the Global Multiplexed Diagnostics market. According to the report, one of the major drivers in the market is an increase in technological innovations to provide efficient and inexpensive devices to diagnose and treat diseases. Advances in technology and innovations in the Healthcare industry have resulted in the development of equipment customized to the needs of patients. Further, the report states that accurate diagnostic testing and the rate of false positive and false negative results are the major issues in the market. The rate of false positive and false negative results, which mostly occur during the window period, is a major challenge to the Global Multiplexed Diagnostics market. Key Vendors - Affymetrix - Agilent Technologies - Biomeurix - F. Hoffmann-La Roche - Illumina - Thermo Fisher Scientific Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Application - Market Segmentation by Technology - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape For more information visit http://www.researchandmarkets.com/research/7pnx6h/global
A: 51.71 (-0.08)
Global High Throughput Screening (HTS) Market 2014-2018: Key Vendors are Agilent, Bio-Rad, Danaher, PerkinElmer, Sigma-Aldrich and Thermo Fisher
M2 - Thu Oct 09, 2:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qzqwwb/global_high) has announced the addition of the "Global High Throughput Screening (HTS) Market 2014-2018" report to their offering. High throughput screening (HTS) is a technology of screening and analyzing a large number of biological or chemical compounds against specific targets. It is generally a fully automated technology and involves instruments, consumables, and software for screening and analysis of compound. The use of liquid handling devices, robotics, and bioinformatics are important aspects of the HTS technology. It is widely used by researchers for drug discovery and other research applications. The high sensitivity, high speed, and easy to use supports the adoption of HTS in research and drug discovery to identify enzymes, ligands for receptors, ion-channels, or other pharmacological targets of interest. HTS is a crucial step in drug discovery for various applications such as assay development, target identification, and primary screening. The analysts forecast the Global HTS market to grow at a CAGR of 7.85 percent over the period 2013-2018. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by Application 08. Market Segmentation by Technology 09. Market Segmentation by Product 10. Geographical Segmentation 11. Buying Criteria 12. Market Growth Drivers 13. Drivers and their Impact 14. Market Challenges 15. Impact of Drivers and Challenges 16. Market Trends 17. Trends and their Impact 18. Vendor Landscape 19. Key Vendor Analysis Companies Mentioned: - Agilent Technologies - Aurora Biomed - Axxam - BMG LABTECH - Becton - Bio-Rad Laboratories - BioFocus DPI - BioTek Instruments - Brooks Automation - Charles River LaboratoriesInternational - Corning - Danaher - Dickinson and Company - DiscoveRx - Dynamic Devices - Evotec - F. Hoffmann-La Roche - Genedata - Intellicyt - Luminex - PerkinElmer - Sigma-Aldrich - Tecan Group - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/qz...lobal_high
A: 51.71 (-0.08), DHR: 74.19 (+2.21), PKI: 40.07 (+0.22)
Keysight Technologies prices private placement of USD1.1bn senior notes
M2 - Wed Oct 08, 8:13AM CDT
Measurement technology company Keysight Technologies said on Tuesday that it has agreed to sell USD500m of 3.30% senior notes due in 2019 plus USD600m of 4.55% senior notes due in 2024.
A: 51.71 (-0.08)
New Frontiers in the US Clinical Chemistry and Immunodiagnostic Markets 2014: Business Challenges, Emerging Technologies, Competitive Landscape
M2 - Wed Oct 08, 3:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/smq5b7/new_frontiers_in) has announced the addition of the "New Frontiers in the US Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape" report to their offering. New Frontiers in the U.S. Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape; is Venture Planning Group's new study of the major business opportunities emerging in the U.S. clinical chemistry and immunodiagnostic markets during the next five years. The report explores future trends in the U.S. market; provides estimates of the specimen, test and sales volumes, as well as major suppliers' sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years. The report provides five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in hospitals, commercial laboratories, physician offices, and ambulatory care centers, including controls, calibrators and consumables. U.S. Market Overview - Estimates of facilities performing clinical chemistry and immunodiagnostic tests. - Test volume and sales projections. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. Market Segmentation Analysis - Comprehensive review of the market dynamics, trends, structure, size, growth, and key suppliers. - Test volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays, by market segment:? Hospitals ? Commercial/Private Laboratories ? Physician Offices/Group Practices The companies analyzed in the report include: - Abbott Laboratories - AdnaGen - Agilent Technologies - Beckman Coulter/Danaher - Biomedical Diagnostics - BioMerieux - Bio-Rad - DiaSorin - Eiken - Fujirebio/Innogenetics - Instrumentation Laboratory - Kyowa Medex - Matritech/Alere - Ortho-Clinical Diagnostics - Quest Diagnostics - Roche - Siemens - Sysmex - Thermo Fisher - Tosoh - Wako - Wallac/PE For more information visit http://www.researchandmarkets.com/research/sm...ontiers_in
ABT: 39.99 (-0.02), A: 51.71 (-0.08), DGX: 57.93 (+0.22), DHR: 74.19 (+2.21)
Fitch Rates Keysight Technologies' $1.1 Billion of Senior Notes at 'BBB'
Business Wire - Tue Oct 07, 2:24PM CDT
Fitch Ratings has assigned a 'BBB' rating to Keysight Technologies Inc.'s (Keysight) $1.1 billion senior notes offering. The ratings affect $1.4 billion of total debt including the company's $300 million undrawn revolving credit facility. The Rating Outlook is Stable. A full list of current ratings follows at the end of this release.
A: 51.71 (-0.08)
TRADE NEWS: Keysight Technologies Introduces USB and LAN Power Sensors with World's Widest Dynamic Range
Business Wire - Tue Oct 07, 10:00AM CDT
Keysight Technologies, Inc. today announced the U2040 X-Series wide dynamic range power sensors, consisting of four USB models for wireless and radar applications, and a dedicated LAN model for satellite testing. With the world's widest dynamic range found in a power sensor and extremely high measurement speed, the U2040 X-Series makes fast, accurate and repeatable power measurements over a wide range of power levels, allowing engineers to improve productivity and lower cost of test.
A: 51.71 (-0.08)
Global Glycobiology/Glycomics Market Outlook 2019: Agilent Tech, Bruker, Danaher, New England Biolabs, Prozyme, Shimadzu, Sigma-Aldrich & Waters Corp Dominates the $512 Million Industry
M2 - Tue Oct 07, 9:59AM CDT
Research and Markets (http://www.researchandmarkets.com/research/x6flwh/glycobiologyglyco) has announced the addition of the "Glycobiology/Glycomics Market by Product, Application & by End User - Global Forecast to 2019" report to their offering. The global glycomics market was valued at $512.38 million in 2014, and is expected to grow at a CAGR of 12.62% to reach $928.11 million in 2019 Glycobiology enzymes, instruments, kits, & reagents find applications in a large number of fields in life science research, as well as diagnostics and drug discovery research. Glycomics products are widely used for the analysis of cell surface markers, which can act as diagnostic or therapeutic targets. Being one of the most widely-used applications of glycomics, drug discovery and development was one of the largest application segments of the global glycomics market in 2014. Glycobiology products are often used in the investigation of the role of glycansin the development of cancer, Alzheimer's, Parkinson's, and infectious diseases like herpes and AIDS. The report provides a granular understanding of the glycomics enzymes, instruments, kits and reagents market. This report segments the global glycomics market on the basis of applications, end users, products and geographies. The application segments included in this report are diagnostics; drug discovery and development; immunology; oncology; and other applications. The end-user segments of this market areacademic research institutes, contract research organizations, and pharmaceutical and biotechnology companies. The product segments included in this report are enzymes, instruments, kits, and reagents. The subsegments of the enzymes product segment included in this report are glycosidases, glycosyltransferases, neuraminidases, sialyltransferases, and other enzymes. The subsegments of the instruments product segment included in this report are antibody arrays; HPLC; lectin arrays; MALDI-TOF; mass spectrometry; and other instruments. The subsegments of the kits product segment included in this report are glycan labeling kits; glycan purification kits; glycan release kits; and other kits. The subsegments of the reagents product segment included in this report are glycoproteins; monosaccharides; oligosaccharides; and other reagents. The major players in the glycomics enzymes, instruments, kits and reagents market include: - Agilent Technologies, Inc. - Bruker Corporation - Danaher Corporation - New England Biolabs - Prozyme - Shimadzu Corporation - Sigma-Aldrich Corporation - Takara Bio - Thermo Fisher Scientific - Waters Corporation For more information visit http://www.researchandmarkets.com/research/x6...ologyglyco
A: 51.71 (-0.08), SIAL: 134.40 (-0.75), DHR: 74.19 (+2.21), WAT: 95.12 (+0.04)
Global RNA Analysis/Transcriptomics Market Outlook 2019: Microarray, PCR, NGS & RNAi Analysis of the $3.77 Billion Industry
M2 - Tue Oct 07, 5:38AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6r3sxh/rna) has announced the addition of the "RNA Analysis/Transcriptomics Market by Technology, by Application, by End-User - Global Forecast to 2019" report to their offering. The global transcriptomics market was valued at $1,743.2 million in 2013 and is expected to reach at $3,773.0 million by 2019, at a CAGR of 13.7% during the forecast period of 2014 to 2019 This market is mainly driven by the increasing technological advancements, increasing investment in research and development by biotechnology and pharmaceutical companies, rising government and private funding, and growing preference for personalized medicines. However, lack of skilled professionals in the transcriptomics field and lack of efficient bioinformatics and data analysis tools to analyze enormous data generated from the high-throughput sequencing technologies expected to restrain the growth of this market to a certain extent The global market covers transcriptomic technologies, applications, and end-users. The RNA Analysis technologies market is segmented as microarray, PCR, sequencing technologies which include Sanger sequencing and NGS, and RNAi gene silencing technology. Each of these technologies market is further sub-segmented as reagents, instruments and software. The applications of RNA analysis covered under the scope of this report are clinical diagnostics, drug discovery, and toxicogenomics. The end-users of RNA analysis are pharmaceutical and biotechnology companies, academic research and government institutes, and hospitals and diagnostic centers. This report also discusses the key market drivers, restraints, opportunities, challenges, and trends in the global transcriptomics market and its submarkets. The global market is divided into four major geographies, namely, North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America holds the largest share of the global transcriptomics market. However, in the forthcoming years, developing regions such as Asia-Pacific (Japan, China, and India) and Latin America are expected to form new revenue-generating pockets for the market players. Economic developments and growing government funding to support new product developments are the key factors driving the growth of market in developing regions. Report Scope Technology - Microarray - PCR - NGS - RNAi Application - Clinical Diagnostics - Drug Discovery - Toxicogenomics End-User - Academic Research - Pharmaceutical Companies - Biotech Companies The prominent players in the market are: - Affymetrix Inc. - Agilent Technologies Inc. - Bio-Rad Laboratories Inc. - GE Healthcare - Illumina Inc. - Qiagen N.V. - F. Hoffmann-La Roche Ltd. - Sigma Aldrich - Fluidigm Corporation - Thermofisher Scientific Inc. For more information visit http://www.researchandmarkets.com/research/6r3sxh/rna
FLDM: 26.40 (+1.52), A: 51.71 (-0.08), ILMN: 160.23 (+6.64), QGEN: 21.32 (-0.15), AFFX: 7.56 (+0.34)
Keysight Technologies Announces Pricing of $1.1 Billion Private Placement Offering of Senior Notes
Business Wire - Mon Oct 06, 4:38PM CDT
Keysight Technologies, Inc. today announced that it has agreed to sell $500 million of 3.30 percent senior notes due in 2019 (the "2019 Notes"
A: 51.71 (-0.08)
Video: HP To Split In About-Face For CEO Whitman
at Investor's Business Daily - Mon Oct 06, 10:08AM CDT
Hewlett-Packard (HPQ) now says two is better than one, announcing early Monday -- after reports surfaced this weekend -- that it will split into two companies by the end of its fiscal 2015, which ends on or near Oct. 31, 2015. One company,...
EBAY: 47.88 (-2.36), A: 51.71 (-0.08), EMC: 26.89 (-0.38), HPQ: 34.00 (+1.20), CSCO: 22.82 (-0.14)